Webinar: Early detection of Peripheral Neuropathy in Prediabetes and Diabetes to improve patient management – March 17th 2023
SUDOSCAN at the AACE Communities MENA 2022
SUDOSCAN at the EASD Annual Meeting 2022
Screening diabetic neuropathy with SUDOSCAN in type 2 diabetes and prediabetes
SUDOSCAN in cardiovascular autonomic neuropathy screening
SUDOSCAN utility to detect foot sudomotor dysfunction in type 1 diabetes without clinical evidence of peripheral neuropathy
Information for US Customers:
Our dedicated US website is now available at us.sudoscan.com. Feel free to visit it for local product information and support.
About Sudoscan
Sudoscan is a class IIa Medical device, Manufactured by Impeto Medical, indicated for early identification and follow-up of peripheral autonomic neuropathies.
For professional use only, read instructions before use. This medical device is a regulated health product which bears, under this regulation, the CE mark
Sudoscan in the world
More information
Contact info
Promotional Communication. The medical devices SUDOSCAN & EZSCAN are regulated health products under the CE certification, Class IIa, according to the European Medical Device directive – SGS Belgium, notified body 1639. The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 2021/01/12
